Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)
Close on Nov 13, 2026Market cap $553.99MP/E –Yield –
Evolent Health total assets
Total assets on the balance sheet at the end of each period.
Evolent Health's total assets was $1.96B at Sep 30, 2026. For fiscal 2025 it was $1.90B, down 25.4% from the year before. Over ten years it grew 6.5% a year on average. The highest annual figure on record is $2.68B in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.90B | -25.4% |
| FY2024 | Dec 31, 2024 | $2.54B | -5.1% |
| FY2023 | Dec 31, 2023 | $2.68B | +47.5% |
| FY2022 | Dec 31, 2022 | $1.82B | +28.0% |
| FY2021 | Dec 31, 2021 | $1.42B | +3.5% |
| FY2020 | Dec 31, 2020 | $1.37B | -8.4% |
| FY2019 | Dec 31, 2019 | $1.50B | -13.0% |
| FY2018 | Dec 31, 2018 | $1.72B | +31.2% |
| FY2017 | Dec 31, 2017 | $1.31B | +9.4% |
| FY2016 | Dec 31, 2016 | $1.20B | +18.2% |
| FY2015 | Dec 31, 2015 | $1.02B | +2629.7% |
| FY2014 | Dec 31, 2014 | $37.20M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.96B | -20.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.97B | -19.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.88B | -29.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.90B | -25.4% |
| Q3 FY2025 | Sep 30, 2025 | $2.45B | -1.9% |
| Q2 FY2025 | Jun 30, 2025 | $2.46B | -0.5% |
| Q1 FY2025 | Mar 31, 2025 | $2.65B | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | $2.54B | -5.1% |
| Q3 FY2024 | Sep 30, 2024 | $2.50B | -6.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.48B | -6.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.64B | +2.1% |
| Q4 FY2023 | Dec 31, 2023 | $2.68B | +47.5% |
| Q3 FY2023 | Sep 30, 2023 | $2.67B | +51.8% |
| Q2 FY2023 | Jun 30, 2023 | $2.65B | +103.0% |
| Q1 FY2023 | Mar 31, 2023 | $2.59B | +93.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.82B | +28.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.76B | +40.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.30B | +0.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.34B | +2.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.42B | +3.5% |
| Q3 FY2021 | Sep 30, 2021 | $1.25B | -9.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.29B | +1.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.31B | -10.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.37B | -8.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.39B | -18.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.27B | -23.1% |
| Q1 FY2020 | Mar 31, 2020 | $1.45B | -11.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.50B | -13.0% |
| Q3 FY2019 | Sep 30, 2019 | $1.71B | +29.6% |
| Q2 FY2019 | Jun 30, 2019 | $1.65B | +25.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.63B | +24.7% |
| Q4 FY2018 | Dec 31, 2018 | $1.72B | +31.2% |
| Q3 FY2018 | Sep 30, 2018 | $1.32B | +1.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.32B | +16.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.31B | +13.2% |
| Q4 FY2017 | Dec 31, 2017 | $1.31B | +9.4% |
| Q3 FY2017 | Sep 30, 2017 | $1.30B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.14B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.15B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.20B | – |
See a number that looks wrong?